CV, VTE Risk Not Seen in Derm Studies of JAK Inhibitors CV, VTE Risk Not Seen in Derm Studies of JAK Inhibitors

' There remains a knowledge gap regarding the risk of JAK inhibitor use and VTE and/or MACE in the dermatologic population, ' the study authors wrote.MDedge News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology News Source Type: news